Skip to main content
Caplight Logo









Suzhou Inhal Pharma Co., Ltd.

Suzhou Inhal Pharma Co., Ltd.

Private
SuzhouHealthcare & Life Scienceshttps://www.inhalpharma.com/

Last Round

Series B

Dec 31, 2025

Total Funding Raised

$27.5M

Company Overview

Suzhou Inhal Pharma Co., Ltd. is a pharmaceutical technology company that specializes in the research and development of inhalation formulations, inhalers, and filling equipment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

dry powder inhalationDPIdrug-device combinationpulmonary drug deliveryinhalation deviceprecision filling equipmentinhaler manufacturingbiotech R&D servicesmicro-dosing systemsrespiratory drug deliveryinhalation formulationCDMOdrug delivery platforminhalation flow monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Suzhou Inhal Pharma Co., Ltd. Comparables

Compare Suzhou Inhal Pharma Co., Ltd. with similar companies based on industry and business-model similarity.

Suzhou Inhal Pharma Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Suzhou Singmed Medical Device Science and Technology Ltd.
82%
Merxin Ltd
81%
Iconovo AB
77%

Suzhou Inhal Pharma Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 31, 2025
Series A ExtensionJun 3, 2025
Series AOct 17, 2023
Pre SeedMar 1, 2021

Key People

Founding team and executive leadership

Kaiqi Shi

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 1642% MoM, from 31 to 540.

  • Mar 1, 2021

    Completed a Pre Seed funding round.

Suzhou Inhal Pharma Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Suzhou Inhal Pharma Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Suzhou Inhal Pharma Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Employee Range8
Year Founded2020
Last FundingDec 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?